2 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow ArginMax: new trials by email Literature Review of ArginMax trials Research Report on ArginMax
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors Placebo, Oral L-Arginine - Male Erectile Disorder, Prostate Cancer | Phase 2 | Completed | Wake Forest University Health Sciences | 140 | 2010-10-01 | 2021-09-28 |
| L-Arginine Supplements in Treating Women Who Are Cancer Survivors ArginMax, Placebo - Sexual Dysfunction, Sexuality and Reproductive Issues | Not applicable | Completed | Wake Forest University Health Sciences | 186 | 2007-05-01 | 2021-09-28 |
Erectile Dysfunction (1) · Prostatic Neoplasms (1) · Radiation Injuries (1) · Sexual Dysfunction, Physiological (1) · Sexuality (1)
Wake Forest University Health Sciences (2)
United States (2)
James J. Urbanic, MD (1) · Kathryn M. Greven, MD (1)
U10CA081851 (2)